Liver fibrosis and pharmaceutical composition for the treatment and prevention of liver cirrhosisAs for this invention, 5- (2- pirajiniru) -4- methyl -1,2- dithiol -3- thion (oruteipurazu (oltipraz))And the dimethyl -4,4'- dimethoxy -5,6,5', 6 ' - jimechirenjiokishibihueniru -2...
Plasma bile acid analysis showed higher levels of GCDCA, TCDCA, GCA and TCA in patients with liver fibrosis than in normal controls. The AUC of GCDCA was the highest. Western blotting showed that GCDCA treatment increased the expression of NLRP3-related proteins and collagen1 in vitro and si...
Background Using the dimethylnitrosamine (DMN) rat model of induced fibrosis, we investigated whether transfer of in vitro–expanded endothelial progenitor cells (EPCs) could reconstitute liver tissue and protect against liver fibrosis.Materials and methods Low-density, adherent, rat bone marrow-derived...
Matsuda M, Seki E. Hepatic stellate cell–macrophage crosstalk in liver fibrosis and carcinogenesis. In: Seminars in liver disease, vol. 03. Germany: Thieme Medical Publishers; 2020. p. 307–20. Google Scholar Allison RD, Tong X, Moorman AC, Ly KN, Rupp L, Xu F, Gordon SC, Holmberg S...
Problem to be solved: to provide a pharmaceutical composition for prevention and treatment of liver disease such as cirrhosis, liver fibrosis, liver failur... チェ,ジンウ 被引量: 0发表: 2020年 Prevention and treatment of intestinal failure-associated liver disease in children. Intestinal failure-...
Effects of prevention and treatment of GanDuQing granule on experimental liver fibrosis in rats 来自 知网 喜欢 0 阅读量: 28 作者:W Li,W Mei,H Li,L Liang,H Xiao,M Chen 摘要: Objective: To study the effect of GanDuQing on the prevention of liver fibrosis in rats. Methods: The male ...
Comparison of effect of formulas clearing away heat and promoting blood circulation on prevention and treatment of liver fibrosis in CCl4 mice doi:10.4268/cjcmm20121223China Journal of Chinese Materia MedicaZHAO ZhiminYU HuiyingPENG YuanREN HongxuTAO YanyanWANG ZhengtaoZHU BangxianLIU ...
In 2023, there were significant advancements in trials of interventions to reduce mortality and morbidity from alcohol-related liver disease, spanning the entire spectrum of disease: primary prevention to reduce overall alcohol-related harm, secondary prevention to attenuate fibrosis progression and tertiary...
Liver fibrosis is a condition of abnormal proliferation of connective tissue due to various types of chronic liver injury often caused by viral infection and chemicals. Effective therapies against liver fibrosis are still limited. In this review, we focu
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention Ann Transl Med, 9 (2020), p. 729 Google Scholar 67 H. Tilg, A.R. Moschen Evolution of inflammation in nonalcoholic fatty liver disease: the multiple para...